The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab - EP1991267

The patent EP1991267 was granted to Biogen Idec MA on Dec 20, 2017. The application was filed on Mar 2, 2007 under application number EP07751993A. The patent is currently recorded with a legal status of "Revoked".

EP1991267

BIOGEN IDEC MA
Application Number
EP07751993A
Filing Date
Mar 2, 2007
Status
Revoked
Oct 15, 2021
Publication Date
Dec 20, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
PHARMACEUTICAL WORKS POLPHARMASep 20, 2018WICHMANN -

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004009169
INTERNATIONAL-SEARCH-REPORTUS2004009169
INTERNATIONAL-SEARCH-REPORTUS2006009385
OPPOSITIONUS2004009169
OPPOSITIONWO2006107962
OPPOSITIONWO2007103112

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents